Quest Diagnostics DGX Total Equity
Total Equity at other companies
Other financials
Where this comes from
Reported directly by Quest Diagnostics in its filing.
Tagged under the XBRL concept us-gaap:StockholdersEquity.
The official record: Quest Diagnostics’s 10-Q, filed April 22, 2026, on SEC EDGAR. View the filing →
Ask your AI about Quest Diagnostics's total equity.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Quest Diagnostics's total equity?
- Quest Diagnostics (DGX) reported total equity of $7.37B in Q1 2026.
- How has Quest Diagnostics's total equity changed year-over-year?
- Quest Diagnostics's total equity increased by 6.3% year-over-year, from $6.93B to $7.37B.
- What is the long-term trend for Quest Diagnostics's total equity?
- Over 5 years (2020 to 2025), Quest Diagnostics's total equity has grown at a 1.2% compound annual growth rate (CAGR), from $6.76B to $7.17B.
- What does total equity mean?
- Net assets attributable to shareholders — total assets minus total liabilities. Represents the book value of shareholders' ownership claim.